PMC:7172841 / 32977-33198 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T223","span":{"begin":36,"end":54},"obj":"Body_part"},{"id":"T224","span":{"begin":162,"end":168},"obj":"Body_part"}],"attributes":[{"id":"A223","pred":"fma_id","subj":"T223","obj":"http://purl.org/sig/ont/fma/fma82785"},{"id":"A224","pred":"fma_id","subj":"T224","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T298","span":{"begin":33,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0001818"},{"id":"T299","span":{"begin":68,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0009141"},{"id":"T300","span":{"begin":68,"end":70},"obj":"http://purl.obolibrary.org/obo/CLO_0050980"},{"id":"T301","span":{"begin":162,"end":168},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T266","span":{"begin":36,"end":54},"obj":"Chemical"},{"id":"T267","span":{"begin":56,"end":59},"obj":"Chemical"}],"attributes":[{"id":"A266","pred":"chebi_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/CHEBI_16412"},{"id":"A267","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_16412"},{"id":"A268","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_52603"},{"id":"A269","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_89981"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T260","span":{"begin":0,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T925","span":{"begin":12,"end":28},"obj":"NCBITaxon:562"},{"id":"T926","span":{"begin":36,"end":54},"obj":"CHEBI:16412;CHEBI:16412"},{"id":"T927","span":{"begin":56,"end":59},"obj":"CHEBI:16412;CHEBI:16412"},{"id":"T928","span":{"begin":129,"end":136},"obj":"NCBITaxon:5478"},{"id":"T929","span":{"begin":137,"end":145},"obj":"NCBITaxon:8296"},{"id":"T930","span":{"begin":162,"end":168},"obj":"UBERON:0001969"},{"id":"T931","span":{"begin":185,"end":196},"obj":"DG_35"},{"id":"T13345","span":{"begin":12,"end":28},"obj":"NCBITaxon:562"},{"id":"T98377","span":{"begin":36,"end":54},"obj":"CHEBI:16412;CHEBI:16412"},{"id":"T29289","span":{"begin":56,"end":59},"obj":"CHEBI:16412;CHEBI:16412"},{"id":"T78784","span":{"begin":129,"end":136},"obj":"NCBITaxon:5478"},{"id":"T50569","span":{"begin":137,"end":145},"obj":"NCBITaxon:8296"},{"id":"T27928","span":{"begin":162,"end":168},"obj":"UBERON:0001969"},{"id":"T75302","span":{"begin":185,"end":196},"obj":"DG_35"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1182","span":{"begin":12,"end":32},"obj":"Species"},{"id":"1183","span":{"begin":129,"end":145},"obj":"Species"},{"id":"1184","span":{"begin":154,"end":161},"obj":"Species"},{"id":"1192","span":{"begin":36,"end":54},"obj":"Chemical"},{"id":"1193","span":{"begin":185,"end":196},"obj":"Chemical"}],"attributes":[{"id":"A1182","pred":"tao:has_database_id","subj":"1182","obj":"Tax:2170726"},{"id":"A1183","pred":"tao:has_database_id","subj":"1183","obj":"Tax:5476"},{"id":"A1184","pred":"tao:has_database_id","subj":"1184","obj":"Tax:9606"},{"id":"A1192","pred":"tao:has_database_id","subj":"1192","obj":"MESH:D008070"},{"id":"A1193","pred":"tao:has_database_id","subj":"1193","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"10 ng/mL of Escherichia coli O55:B5 lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 × 105 colony forming units of heat-killed Candida albicans; 25% of patient plasma; or 10 μg/mL of Tocilizumab (Roche, Athens, Greece)."}